SALT LAKE CITY, April 27, 2011 /PRNewswire/ -- Paradigm Medical Industries, Inc. (OTC: PDMI.PK) announced its success at the annual meeting of Vision Source, an optometric organization, which was held at the Houston Convention Center in Houston, Texas from April 14-17, 2011. Over 2,300 private practice optometrists from many of the most highly regarded practices in the United States were in attendance at the annual meeting. The meeting provided opportunities for participating optometrists to attend practice building seminars, benefit from shared peer experience, and purchase equipment from vendors approved by Vision Source.
"This important annual meeting with Vision Source's members resulted in creating many new sales opportunities for Paradigm's products, including the Blood Flow Analyzer™, the P60 UBM Ultrasound Biomicroscope, the new LD 500 autoperimeter, and the new Paramax™. New sales were made and numerous quality leads that will lead to future sales made the meeting a great success," said Stephen L. Davis, Paradigm's President and Chief Executive Officer.
Mr. Davis added, "The opportunity to attend the meeting filled an important sales objective for Paradigm to reestablish its working relationship with the Vision Source group and introduce Paradigm's high technology diagnostic eye care instruments for early detection of glaucoma and other eye disorders to this important professional eye care group."
Vision Source is an invitation only, private optometric organization that requires its members to pay an annual membership fee to belong and benefit from its membership. Members learn new practice building skills, improve staff development, and gain valuable general business tips. Members also enjoy reduced pricing from approved vendors who financially support these efforts.
About Paradigm Medical Industries, Inc.
Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes ophthalmic diagnostic instruments and related products for early detection of glaucoma and other eye disorders. The Company's primary objective is to capture a niche market within the glaucoma and ultrasound microscopy fields. The Company markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States and internationally.
This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.
Contact: Stephen L. Davis
President and Chief Executive Officer
SOURCE Paradigm Medical Industries, Inc.